The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Alimera Sciences, Inc(NASDAQ:ALIM) 
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of ...
Website: http://www.alimerasciences.com
Founded: 2003
Full Time Employees: 122
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Alimera Sciences Days Payable Outstanding ttm (DPO)
Alimera Sciences Days Receivable Outstanding ttm (DSO)
Alimera Sciences Days Inventory Outstanding ttm (DIO)
Alimera Sciences Op Cashflow Per Share ttm
Alimera Sciences Free Cashflow Per Share ttm
Alimera Sciences Cash Per Share ttm
Alimera Sciences P/S ratio ttm
Alimera Sciences (GAAP) P/E ratio ttm
Alimera Sciences P/B ratio ttm
No extra charts and metrics for this ticker.